SLC1A5, whose ablation sensitized tumors to the mTORC1 inhibitor rapamycin, was also essential for metabolic reprogramming and the rapid proliferation of KRAS-mutant colorectal cancer [160]. Here, SLC1A5 is linked to colorectal cancer.